Stay updated on RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Sign up to get notified when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.

Latest updates to the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page
- Check3 days agoChange DetectedA new revision entry, Revision: v3.6.2, was added to the study record history, signaling the latest update to the record; the prior revision v3.6.0 is shown as removed in this change set.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedRecruitment status changed to 'No longer looking for participants' and the study record version was updated to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.3%

- Check24 days agoChange DetectedA new revision entry v3.5.5 was added to the study history, replacing the previous v3.5.4 and indicating an update to the page's version history.SummaryDifference0.1%

- Check46 days agoChange DetectedThe Record History now shows Revision: v3.5.4 as the current version, replacing Revision: v3.5.3 in the history.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s displayed revision/version string was updated from v3.5.2 to v3.5.3, reflecting a site/UI software update rather than a change to the study record details.SummaryDifference0.1%

- Check74 days agoChange DetectedSponsor name updated to 'Replimune, Inc.' and a new revision 'Revision: v3.5.2' was added; the previous entries 'Replimune Inc.' and 'Revision: v3.5.0' were removed.SummaryDifference0.3%

Stay in the know with updates to RP2 Monotherapy and RP2 with Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RP2 Monotherapy and RP2 with Nivolumab Clinical Trial page.